Literature DB >> 6484793

Sex related survival differences in instances of melanoma.

D S Reintgen, D E Paull, H F Seigler, E B Cox, K S McCarty.   

Abstract

While data concerning melanoma survival differences between the sexes as they relate to anatomic site, stage and age is scattered throughout the literature, few single studies on one large population of patients with melanoma have specifically addressed all the confounding variables proposed to account for such sex related survival differences. Data were collected for 1,489 patients with melanoma observed at Duke University Comprehensive Cancer Center. Females had a more favorable prognosis than males. This survival difference could not be fully explained by differences in the anatomic site of the primary, Clark level of invasion, histologic type or ulceration of the primary lesion or age at diagnosis between males and females. There is growing epidemiologic and biochemical evidence that melanoma may be affected by sex hormones.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6484793

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  5 in total

1.  Sex, pregnancy, hormones, and melanoma.

Authors:  I Jatoi; M E Gore
Journal:  BMJ       Date:  1993-07-03

Review 2.  Recent advances in the care of the patient with malignant melanoma.

Authors:  D Reintgen; C M Balch; J Kirkwood; M Ross
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

3.  Gender and ploidy in cancer survival.

Authors:  Susanne Schulze; Iver Petersen
Journal:  Cell Oncol (Dordr)       Date:  2011-03-22       Impact factor: 6.730

Review 4.  Is oestrogen an important player in melanoma progression?

Authors:  Marcelina E Janik; Klaudyna Bełkot; Małgorzata Przybyło
Journal:  Contemp Oncol (Pozn)       Date:  2014-11-05

5.  Estrogen Receptor Alpha (ESR1) Single-Nucleotide Polymorphisms (SNPs) Affect Malignant Melanoma Susceptibility and Disease Course.

Authors:  Hanna Glatthaar; Judith Katto; Thomas Vogt; Ulrich Mahlknecht
Journal:  Genet Epigenet       Date:  2016-02-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.